Clinical Trials Directory

Trials / Completed

CompletedNCT02825121

Evaluation of Monitoring Neuromuscular Blockade the Flexor Hallucis Compared to the Adductor Pollicis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Current guidelines recommend monitoring of neuromuscular blockade at the adductor pollicis by stimulation of the ulnar nerve at the wrist. However, in certain situations (laparoscopic surgery, cranial surgery or surgical comfort, arterial catheterization), it is impossible to access the patient's wrists, delaying monitoring, antagonizing the neuromuscular block, the emergence from anesthesia and patient extubation , leading in some cases to single injections lack of control of the reversal of the patient. To overcome these technical difficulties, a group nerve / muscle looks interesting and often easily accessible to the anesthesiologist. The stimulation of the posterior tibial nerve can observe a response to the flexor hallucis brevis muscle and allows quick access to monitoring the reversal before the end of the intervention. The primary outcome was to compare the speed of recovery from neuromuscular block flexor hallux versus that of the adductor pollicis. The secondary objective was to compare the speed of installation of deep neuromuscular block flexor hallucis versus that of the adductor pollicis. This is a prospective, exploratory, uncontrolled, single-center for routine care. Are included all aged patients over 18 years, ASA I or II, without guardianship, having no known allergy to Atracurium, without neuromyopathy known, emergency surgery or full stomach, predictable difficult intubation .

Conditions

Interventions

TypeNameDescription
DEVICEMonitoring Neuromuscular Blockade the Flexor Hallucis
DEVICEMonitoring Neuromuscular Blockade adductor of the thumb.

Timeline

Start date
2016-02-01
Primary completion
2017-09-01
Completion
2017-09-01
First posted
2016-07-07
Last updated
2017-10-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02825121. Inclusion in this directory is not an endorsement.